Home / Blood Tests / ROMA-PRE
ROMA-PRE
Overview of the ROMA™ Test
The Risk of Ovarian Malignancy Algorithm (ROMA™) test is designed to evaluate the likelihood of ovarian cancer in women presenting with a pelvic mass.
Key Factors Assessed
The test combines measurements of HE4 and CA125 biomarkers along with the patient’s menopausal status.
Purpose and Clinical Use
ROMA™ helps healthcare providers assess the risk of ovarian malignancy to support timely and accurate clinical decision-making.
| Price | £112.0 |
|---|---|
| Categories | | All |
| Turnaround Time | nan |
| LIS Code | ROMA-PRE |
| Exams Included | No Markers Included |
| Enquire Now (020 3633 2371) WhatsApp Now (+4474 4807 7654) Book Now |
Our Professional Services
Our partner laboratory, Medical Diagnosis, is UKAS ISO 15189 accredited, and Medical Diagnosis Victoria is registered with the Care Quality Commission (CQC), ensuring all diagnostic testing meets the highest UK standards of quality and accuracy. Medical Diagnosis Victoria is authorised to provide Testosterone Replacement Therapy (TRT) and related clinical services, which are delivered following appropriate medical assessment by GMC-registered doctors with extensive clinical experience.
More About It